Table 2.
Author, year | Study type | Patients/studies | Findings |
---|---|---|---|
Maijers et al. [2], Neth J Med, PMID: 24394743 | Descriptive cohort study | n = 80 women with SBIs and subsequent onset of unexplained symptoms | After explantation, 36/52 (69%) women with systemic symptoms experienced significant reduction in symptoms |
Colaris et al. [7], Immunol Res., PMID: 27406737 | Comparative study | n = 100 patients diagnosed in 2014 with ASIA | 54 patients underwent explantation, of which 27 (50%) experienced improvement of complaints |
de Boer et al. [5], Immunol Res., PMID: 27412295 | Systematic review | 23 studies were analyzed, N = 622 patients who underwent explantation of breast implants | Explantation improved complaints in 469 of 622 (75%) patients. In patients with autoimmune diseases, additional immunosuppressive therapy increased improvement |
Lee et al. [36], Plast Reconstr Surg Glob Open, PMID: 32440423 | Prospective cohort study | n = 50 patients with BII | Explantation improved or resolved some symptoms in 39 out of 44 patients (78%) |
Wee et al. [73], Ann Plast Surg, PMID 32530850 | Retrospective cohort study | n = 552 women with SBIs undergoing explantation with post-operative symptom follow-up | Improvement across 11 common symptom domains following removal of breast implants and total capsulectomy |
Glicksman et al. [72], Aesthetic Surg J, PMID: 34915566 | Prospective cohort study | n = 150 women undergoing explantation of SBIs versus women undergoing mastopexy | Symptoms of BII significantly improved for greater than 6 months in women undergoing explantation of SBI |
Katsnelson et al. [39], Plast Reconst Surg Glob Open, PMID 34513545 | Retrospective cohort study | n = 248 women with SBIs undergoing explantation | Of 46 women who responded to postoperative symptom follow-up, 96% reported improvement in symptoms |